A Status Neutral Approach prior to initiating PrEP; An Overview
- Discuss epidemiology and the status neutral approach
- Discuss the essential aspects of conducting a sexual and drug history to identify patients at increased risk for HIV transmission who may benefit from PrEP.
- Describe the FDA –approved drug regimen for PrEP.
- Identify the clinical and behavioral parameters for instituting PrEP/PEP therapy.
- Describe the clinical and behavioral parameters for instituting and monitoring the ongoing safety and effectiveness of PrEP in patients receiving treatment.
- Discuss integration sexual histories and PrEP initiation into your site’s workflow
- Identify resources for PrEP services for patients who are uninsured or underinsured.
- Discuss the PrEP Pipeline
There is no accreditation offered for this course.
Contact Abby Plusen at aplusen@som.umaryland.edu with any questions.